Is Streamline Health Solutions Inc. (STRM) positioned for future growth?

Streamline Health Solutions Inc. (NASDAQ: STRM) stock jumped 7.07% on Wednesday to $1.97 against a previous-day closing price of $1.84. With 0.19 million shares changed hands, the volume of the stock remained heavier than its average volume of 48610.0 shares. During the session, the Health Information Services company that operates in wider Healthcare sector, reached to the highest price of $2.0100 whereas the lowest price it dropped to was $1.8100. The 52-week range on STRM shows that it touched its highest point at $1.89 and its lowest point at $1.04 during that stretch. It currently has a 1-year price target of $3.00. Beta for the stock currently stands at 1.11.

China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of STRM was up-trending over the past week, with a rise of 13.22%, but this was up by 34.01% over a month. Three-month performance surged to 20.86% while six-month performance rose 57.60%. The stock gained 24.68% in the past year, while it has gained 32.21% so far this year. A look at the trailing 12-month EPS for STRM yields -0.22 with Next year EPS estimates of -0.15. For the next quarter, that number is -0.06. This implies an EPS growth rate of -1.50% for this year and 34.80% for next year. EPS is expected to grow by 15.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 12.20%.

Float and Shares Shorts:

At present, 47.23 million STRM shares are outstanding with a float of 35.71 million shares on hand for trading. On Oct 13, 2022, short shares totaled 94590.0, which was 0.19% higher than short shares on Sep 14, 2022. In addition to Mr. Wyche T. Green III as the firm’s Chairman, Pres & CEO, Mr. Thomas J. Gibson serves as its Sr. VP, CFO & Principal Accounting Officer.

Institutional Ownership:

Through their ownership of 23.69% of STRM’s outstanding shares, institutional investors have minority control over the company. Other institutions hold — of STRM, in contrast to — held by mutual funds. Shares owned by individuals account for –. With a 1.63% stake in STRM, the Vanguard Total Stock Market Index is the largest stakeholder. A total of 899,798 shares are owned by the mutual fund manager. The Herald Investment Trust Plc, which owns about 1.08% of STRM stock, is the second-largest Mutual Fund holder. It holds 592,685 shares valued at 1.07 million. Vanguard Extended Market Index Fu holds 1.06% of the stake in STRM, owning 582,649 shares worth 1.05 million.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for STRM since 2 analysts follow the stock currently. There are 2 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With STRM analysts setting a high price target of $3.00 and a low target of $3.00, the average target price over the next 12 months is $3.00. Based on these targets, STRM could surge 52.28% to reach the target high and rise by 52.28% to reach the target low. Reaching the average price target will result in a growth of 52.28% from current levels.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. STRM will report FY 2023 earnings on 04/26/2023. Analysts have provided yearly estimates in a range of -$0.23 being high and -$0.25 being low. For STRM, this leads to a yearly average estimate of -$0.24. The surprise factor in the prior quarter was -$0.01. Based on analyst estimates, the high estimate for the next quarter is -$0.06 and the low estimate is -$0.07. The average estimate for the next quarter is thus -$0.07.

Summary of Insider Activity:

Insiders traded STRM stock several times over the past three months with 9 Buys and 0 Sells. In these transactions, 1,980,300 shares were bought while 0 shares were sold. The number of buy transactions has increased to 15 while that of sell transactions has risen to 11 over the past year. The total number of shares bought during that period was 2,521,031 while 92,337 shares were sold.

Leave a Comment

Your email address will not be published. Required fields are marked *




The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.

Receive Best Stock To Trade Before The Opening Bell



100% Free. Stop Anytime. No Spam